JAZZ PHARMACEUTICALS PLC - Daily - Technical analysis published on 07/12/2019 (GMT)
- 317
- 0
- Who voted?
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Trends
Court terme:
Strongly bullish
De fond:
Strongly bullish
Technical indicators
39%
22%
39%
My opinion
Bullish above 135.83 USD
My targets
144.62 USD (+4.62%)
151.15 USD (+9.35%)
My analysis
All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on JAZZ PHARMACEUTICALS PLC as long as the price remains well above 135.83 USD. The buyers” bullish objective is set at 144.62 USD. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 151.15 USD. If there is any crossing, the next objective would be the resistance located at 162.01 USD. However, beware of bullish excesses that could lead to a possible short-term correction; but this possible correction would not be tradeable.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
JAZZ PHARMACEUTICALS PLC rating 138.23 USD. The price is lower by -2.48% since the last closing with the lowest point at 136.49 USD and the highest point at 141.32 USD. The deviation from the price is +1.27% for the low point and -2.19% for the high point.136.49
141.32
138.23
The Central Gaps scanner detects the formation of a bearish gap marking the strong presence of sellers ahead of buyers at the opening. This formed a quotation gap.
Opening Gap DOWN
Type : Bearish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of JAZZ PHARMACEUTICALS PLC indicates that the overall trend is strongly bullish. The signals given by the moving averages are 89.29% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators market scanner is currently detecting a bullish signal that could impact this trend:
Moving Average bullish crossovers : MA50 & MA100
Type : Bullish
Timeframe : Daily
An assessment of technical indicators does not currently provide any relevant information on the direction of future price movements.
Central Indicators, the detector scanner for these technical indicators has recently detected several signals:
Pivot points : price is under support 1
Type : Neutral
Timeframe : Weekly
Pivot points : price is under support 3
Type : Neutral
Timeframe : Daily
The analysis of the price chart with Central Patterns scanners does not return any result.
For a small setback in the very short term, the Central Candlesticks scanner currently notes the presence of this bearish pattern in Japanese candlesticks:
Bearish harami
Type : Bearish
Timeframe : Daily
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 125.76 | 131.06 | 135.83 | 138.23 | 144.62 | 151.15 | 162.01 |
| Change (%) | -9.02% | -5.19% | -1.74% | - | +4.62% | +9.35% | +17.20% |
| Change | -12.47 | -7.17 | -2.40 | - | +6.39 | +12.92 | +23.78 |
| Level | Major | Major | Major | - | Major | Minor | Major |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 138.81 | 139.92 | 140.83 | 141.94 | 142.85 | 143.96 | 144.87 |
| Camarilla | 141.19 | 141.38 | 141.57 | 141.75 | 141.94 | 142.12 | 142.31 |
| Woodie | 138.72 | 139.87 | 140.74 | 141.89 | 142.76 | 143.91 | 144.78 |
| Fibonacci | 139.92 | 140.69 | 141.17 | 141.94 | 142.71 | 143.19 | 143.96 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 135.56 | 138.09 | 139.58 | 142.11 | 143.60 | 146.13 | 147.62 |
| Camarilla | 139.97 | 140.33 | 140.70 | 141.07 | 141.44 | 141.81 | 142.18 |
| Woodie | 135.04 | 137.83 | 139.06 | 141.85 | 143.08 | 145.87 | 147.10 |
| Fibonacci | 138.09 | 139.63 | 140.57 | 142.11 | 143.65 | 144.59 | 146.13 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 52.10 | |
| MACD (12,26,9): | 2.3100 | |
| Directional Movement: | -2.37 | |
| AROON (14): | 57.14 | |
| DEMA (21): | 140.99 | |
| Parabolic SAR (0,02-0,02-0,2): | 144.42 | |
| Elder Ray (13): | -0.59 | |
| Super Trend (3,10): | 132.37 | |
| Zig ZAG (10): | 138.23 | |
| VORTEX (21): | 1.1000 | |
| Stochastique (14,3,5): | 73.34 | |
| TEMA (21): | 142.70 | |
| Williams %R (14): | -45.66 | |
| Chande Momentum Oscillator (20): | 6.92 | |
| Repulse (5,40,3): | -1.1000 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | 0.2200 | |
| Courbe Coppock: | 13.45 |
| MA7: | 141.59 | |
| MA20: | 137.21 | |
| MA50: | 135.02 | |
| MA100: | 134.94 | |
| MAexp7: | 140.56 | |
| MAexp20: | 138.19 | |
| MAexp50: | 135.90 | |
| MAexp100: | 136.01 | |
| Price / MA7: | -2.37% | |
| Price / MA20: | +0.74% | |
| Price / MA50: | +2.38% | |
| Price / MA100: | +2.44% | |
| Price / MAexp7: | -1.66% | |
| Price / MAexp20: | +0.03% | |
| Price / MAexp50: | +1.71% | |
| Price / MAexp100: | +1.63% |
News
The last news published on JAZZ PHARMACEUTICALS PLC at the time of the generation of this analysis was as follows:
- Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
- Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
- Jazz Pharmaceuticals Announces Webcast for Sunosi Investor Update
- Jazz Pharmaceuticals Announces Webcast for Sunosi Investor Update
- Jazz Pharmaceuticals Receives Schedule IV Designation from DEA for Sunosi™ (solriamfetol)
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis JAZZ PHARMACEUTICALS PLC - Daily